Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer

Background Management of hypopharynx cancer is often extrapolated from larynx cancer. This report analyses treatment patterns and survival limited to hypopharynx cancer using the National Cancer Database (NCDB). Methods There are 9314 patients diagnosed with hypopharynx cancer between 2004 and 2016....

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2021-10, Vol.43 (10), p.3042-3052
Main Authors: Burbure, Nina, Handorf, Elizabeth, Ridge, John A., Bauman, Jessica, Liu, Jeffrey C., Giri, Anshu, Galloway, Thomas J.
Format: Article
Language:English
Subjects:
Cancer
chemoradiation
Chemoradiotherapy
Head & neck cancer
Human papillomavirus
hypopharyngeal
Hypopharynx
Laryngeal cancer
Larynx
pyriform sinus
Surgery
Survival
Throat cancer
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Management of hypopharynx cancer is often extrapolated from larynx cancer. This report analyses treatment patterns and survival limited to hypopharynx cancer using the National Cancer Database (NCDB). Methods There are 9314 patients diagnosed with hypopharynx cancer between 2004 and 2016. The association between treatment modality and survival was analyzed using Kaplan–Meier survival curves and multivariable Cox regression. Results Five‐year overall survival ranged from 45% for stage I to 21% for stage IVB. Treatment modality did not influence survival in stage I/II. For stage III/IV, chemoradiation and surgery + adjuvant therapy were equivalent. Surgery yielded improved survival for T4 disease. Human papillomavirus (HPV)‐positive tumors were present in 21% and were associated with improved hazard ratio of death (0.60, p = 
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.26793